In order to advance therapeutics, medical devices/diagnostics, and digital health technologies across campus, the Technology Development Group (TDG), UCLA Health / David Geffen School of Medicine (DGSOM), UCLA Henry Samueli School of Engineering & Applied Science and the College's Divisions of Life Sciences and Physical Sciences are collaborating to present the UCLA Innovation Fund. This opportunity is open to UCLA faculty from all Schools who have signed the UCLA Patent Policy.
The fund has a singular mission: To enable technologies to move quickly from the lab to the market, and bridge the gap between academic research and industry/venture capital interest.
Funding will be used to advance a project along to reach a key project-specific milestone, further enabling these technologies to be licensed to an existing company or a startup. These funds are to support commercialization activities that would not be supported by basic research grants.
There is a three-step application process, which requires a Letter of Intent, Full Application (by invitation only), and a Pitch Presentation.
Here’s how to find out.
The UCLA Innovation Fund provides the opportunity for faculty members who have made discoveries that have the potential to meet unmet medical needs to find the team members that they need with the expertise in finance, business and other areas that are required to commercialize a business idea.
See the full schedule to submit your idea below.
Letter of Intent (LOI) Due (all tracks)
Internal Scientific Panel & Business/IP Review
The 4 week timeline will be used as time spent to conduct reviews and write therapeutic decision letters
For general questions about the process contact:
Consultations are available, if desired, with representatives from the respective fund tracks. These sessions are meant to review ideas, processes or patent consultation.
Available beginning May 1, 2017 through submission process
Consulting - Division of Life Sciences:Utpal Banerjee, PhD email@example.com
Consulting - David Geffen School of Medicine:Judy Gasson, PhD JGasson@mednet.ucla.edu
Consulting - UCLA Health / DGSOM:Desert Horse-Grant firstname.lastname@example.org
Consulting - Technology Development Group:Tom Lipkin, PhD email@example.com
Consulting - School of Engineering:Harold Monbouquette, PhD firstname.lastname@example.org
Consulting - Division of Physical Sciences:Brooke Sanders email@example.com
Technologies will be separated into three tracks: therapeutics, medical devices/diagnostics, and digital health. Full applications will be reviewed by both an academic panel to evaluate scientific merit and a business review panel to assess commercial potential. Applications with high scores for both scientific and business merit will advance to a pitch presentation where an external advisory committee comprised of industry executives, investors, and serial entrepreneurs will be assembled for each track. Inventors will pitch, and the committee will identify fundable projects, articulate key experiments to conduct, and lend additional scientific and business insight. The leadership of TDG, UCLA Health/DGSOM, the School of Engineering, the Division of Life Sciences, and the Division of Physical Sciences will then work collaboratively but with some independence to make final funding decisions; successful projects may be funded by TDG, UCLA Health / DGSOM, Henry Samueli School of Engineering and Applied Sciences (HSSEAS), Life Sciences, and Physical Sciences.
In addition to funding, most or all selected projects will be assigned a Project Manager (PM). Aided by the inventors, each PM will be required to create a milestone-driven project plan, timeline, and budget. Funding is contingent on meeting these predetermined milestones, and PMs will determine how funds are spent.
Applications are open to Principal Investigators (PIs) across campus, regardless of the schools involved. We expect many collaborative projects between research groups on campus. Proposal budgets are required to be as fiscally conservative as possible, and are dependent on meeting project-specific milestones.
Funding may range from $50,000 - $200,000 per project depending on need.
Funds may be used for both internal project development and for outside vendors/consultants/contractors. Please note this is not a typical award. Therefore, money will be released based on following the work plan, meeting milestones, and achieving results. If a project fails to meet a certain milestone, the reminder of funding may be withdrawn.
The PI must be present for the pitch presentation. It will be a 15 minute pitch followed by 15 minutes of questions. A Tech Fellow from TDG will be matched with PIs to assist with their pitches. Practice session(s) are required with a representative of TDG and a representative of either the Health System/DGSOM, the School of Engineering, the Division of Life Sciences, or the Division of Physical Sciences.
General evaluation criteria for all LOIs and full applications:
In addition to specified milestone reports, the PI and the Project Manager (if applicable) of each funded award must submit a six-month progress report and final annual report. The reports will include:
The Letter of Intent document should include the following three items assembled into a single PDF:
Please assemble the LOI, Biosketches, Other Support pages, and Submitted Applications documents into a single PDF, which can be uploaded by clicking the 'Submit Your Application' button below.
Letter of Intent (LOI) submissions for all tracks are due by no later than May 30, 2017.
Full applications will be invited from a select group of faculty who have submitted LOIs.
Instructions for full applications are as follows:
Applications are by invitation only. Notices will be sent to the selected individuals, to submit no later than July 17, 2017 for the Therapeutic Track. All other track deadlines will be announced on a rolling schedule.
SUBMIT YOUR Application